FLNA
Filana Therapeutics, Inc.
NASDAQ: FLNA · HEALTHCARE · BIOTECHNOLOGY
$1.44
-7.69% today
Updated 2026-04-29
Market cap
$77.78M
P/E ratio
—
P/S ratio
2.54x
EPS (TTM)
$-1.88
Dividend yield
—
52W range
$1 – $5
Volume
0.5M
Filana Therapeutics, Inc. (FLNA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-82.70%
ROA
-27.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | — | $-32.38M | — | — | — |
| 2022 | $0.00 | $-76.25M | — | — | — |
| 2023 | $0.00 | $-97.22M | — | — | — |
| 2024 | $0.00 | $-24.34M | — | — | — |
| 2025 | $0.00 | $-90.97M | — | — | — |